Onyx™ Liquid Embolic IDE Clinical Study

ClinicalTrials.gov ID: NCT06742801

Public ClinicalTrials.gov record NCT06742801. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 5, 2026, 11:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PELE IDE Clinical Study, Peripheral Onyx™ Liquid Embolic Safety and Effectiveness of The Onyx™ LES for Embolization of Arterial Hemorrhage in the Peripheral Vasculature

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.

Study identification

NCT ID: NCT06742801
Recruitment status: Recruiting
Study type: Interventional
Phase: Not applicable
Lead sponsor: Medtronic Endovascular; Industry
Enrollment: 119 participants

Conditions and interventions

Conditions

Interventions

Onyx™ Liquid Embolic System Device

Device

Eligibility (public fields only)

Age range: 22 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 8, 2025
Primary completion: Mar 31, 2027
Completion: Apr 30, 2027
Last update posted: Jul 23, 2026

2025 – 2027

United States locations

U.S. sites: 18
U.S. states: 14
U.S. cities: 18

Facility	City	State	ZIP	Site status
Mayo Clinic	Phoenix	Arizona	85054	Recruiting
University of California, Irvine	Irvine	California	92627	Recruiting
Stanford Medical Center	Palo Alto	California	94304	Recruiting
UCHealth University of Colorado Hospital	Aurora	Colorado	80045	Recruiting
Yale New Haven	New Haven	Connecticut	06510	Recruiting
University of Chicago	Chicago	Illinois	60637	Recruiting
University of Iowa Hospitals and Clinics	Iowa City	Iowa	52242	Recruiting
Masschusetts General Hospital	Boston	Massachusetts	02114	Recruiting
CHI Health Creighton University Medical Center-Bergan-Mercy	Omaha	Nebraska	68124	Recruiting
Rutgers New Jersey Medical School	Newark	New Jersey	07103	Suspended
Albany Medical Center	Albany	New York	12208	Recruiting
The Mount Sinai	New York	New York	10029	Recruiting
University Hospitals Cleveland Medical Center	Cleveland	Ohio	44106	Recruiting
The Ohio State University	Columbus	Ohio	43210	Recruiting
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15237	Recruiting
Vanderbilt University Medical Center	Nashville	Tennessee	37212	Recruiting
Univ Of Texas Southwestern	Dallas	Texas	75235	Recruiting
The University of Texas Health Science Center at Houston	Houston	Texas	77030	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06742801, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 23, 2026 · Synced Sep 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06742801 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →